Annarita Ianniello

Role of 18FDG PET/CT in patients treated with 177Lu-DOTATATE for advanced differentiated neuroendocrine tumours

Stefano Severi, Oriana Nanni, Lisa Bodei et al. · European Journal of Nuclear Medicine and Molecular Imaging · 2013 · 143 citations · Full text

Positron Emission Tomography, Oncologic Imaging, Medicine +8

177 Lu-Dota-octreotate radionuclide therapy of advanced gastrointestinal neuroendocrine tumors: results from a phase II study

Giovanni Paganelli, Maddalena Sansovini, A. Ambrosetti et al. · European Journal of Nuclear Medicine and Molecular Imaging · 2014 · 121 citations

Endocrine Oncology, Gastrointestinal Oncology, Medicine +11

Long-term follow-up and role of FDG PET in advanced pancreatic neuroendocrine patients treated with 177Lu-D OTATATE

Maddalena Sansovini, Stefano Severi, Annarita Ianniello et al. · European Journal of Nuclear Medicine and Molecular Imaging · 2016 · 117 citations

Medicine, Neuroendocrine Disorder, Endocrinology +4

Peptide receptor radionuclide therapy with 177Lu-DOTATATE in advanced bronchial carcinoids: prognostic role of thyroid transcription factor 1 and 18F-FDG PET

Annarita Ianniello, Maddalena Sansovini, Stefano Severi et al. · European Journal of Nuclear Medicine and Molecular Imaging · 2015 · 100 citations · Full text

Prognostic Role, Medicine, Radionuclide Therapy +13

Investigation of receptor radionuclide therapy with 177Lu-DOTATATE in patients with GEP-NEN and a high Ki-67 proliferation index

Silvia Nicolini, Stefano Severi, Annarita Ianniello et al. · European Journal of Nuclear Medicine and Molecular Imaging · 2018 · 78 citations

Neuro-oncology, Engineering, Radiation Therapy +11